Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

Symptoms and the Diagnostic Process

At a Glance

Glioblastoma causes symptoms like focal weakness, morning headaches, memory changes, and seizures. While an MRI with contrast can identify suspicious brain lesions, a tissue biopsy is mandatory to confirm the diagnosis, rule out other conditions, and analyze the tumor's genetic profile.

The path to a glioblastoma diagnosis often begins when the brain’s normal functions are disrupted by a growing mass. Because the brain controls everything from movement to personality, the symptoms can be as diverse as they are distressing. Understanding how these symptoms manifest and how doctors use technology to investigate them is a critical part of your journey.

How Glioblastoma Presents

Glioblastoma (GBM) symptoms are often “focal,” meaning they relate to the specific area of the brain where the tumor is located. However, some symptoms are more generalized due to increased pressure inside the skull.

  • Focal Neurological Deficits: These are specific losses of function, such as weakness or numbness on one side of the body, difficulty with balance, or aphasia (trouble speaking or understanding language) [1][2].
  • Vision and Sensory Changes: You may experience blurred vision, double vision, or a loss of peripheral vision.
  • Headaches: These are often worse in the morning and may be accompanied by nausea or vomiting.
  • Cognitive and Mood Alterations: Some of the most frequently overlooked symptoms include neurobehavioral changes, such as sudden irritability, depression, memory lapses, or a general sense of “brain fog” [3].
  • Seizures: A new-onset seizure in an adult is a common “red flag” that leads to immediate brain imaging.

The Role of MRI

The Magnetic Resonance Imaging (MRI) scan is the gold standard for visualizing a suspected brain tumor. When a doctor suspects GBM, they typically use a “contrast agent” (gadolinium) injected into the vein to make the tumor clearer on the screen.

In a classic GBM presentation, the MRI often shows ring enhancement [4][5]. This looks like a bright, glowing circle surrounding a darker center. The dark center represents necrosis—areas where the tumor is growing so fast that it has outstripped its own blood supply and the cells in the middle have died [6].

Because GBM can sometimes look like other conditions, doctors may use advanced imaging techniques:

  • Perfusion-Weighted Imaging (PWI): Measures blood flow to see how “aggressive” the blood vessel growth is [7].
  • Diffusion-Weighted Imaging (DWI): Looks at how water molecules move through the tissue to help distinguish a tumor from an abscess [8][9].
  • MR Spectroscopy (MRS): Analyzes the chemical metabolites within the brain to check for “signatures” of cancer.

Why Tissue is Mandatory

While an MRI can strongly suggest a glioblastoma, it cannot provide a definitive diagnosis on its own. Tissue biopsy or surgical resection is mandatory [10]. This is because several “mimics” can look nearly identical to GBM on a scan, including:

  • Brain Abscesses: Serious infections that also create ring-enhancing lesions [11].
  • Primary Central Nervous System Lymphoma (PCNSL): A different type of cancer that requires a completely different treatment path [12].
  • Metastatic Tumors: Cancer that has spread to the brain from elsewhere in the body, like the lungs or breast [13].

Beyond confirming it is cancer, the tissue is required for molecular analysis. Under the current (2021) WHO classification standards, a tumor is not just defined by what it looks like under a microscope, but by its genetic markers [14]. Specifically, doctors must test for IDH mutation status to rule out an IDH-mutant astrocytoma. If the tumor is IDH-wildtype and looks like a lower-grade glioma, but has certain aggressive genetic features, it will be “upgraded” to a molecular glioblastoma (Grade 4), which requires more intensive treatment [10][15]. Obtaining this tissue is the only way to ensure you receive the correct therapy for your specific tumor type.

Common questions in this guide

What are the first symptoms of a glioblastoma?
Early symptoms often depend on the tumor's location and can include specific issues like weakness on one side, trouble speaking, or vision changes. Other common warning signs include morning headaches, new-onset seizures, and changes in personality, mood, or memory.
Why is an MRI required if a brain tumor is suspected?
An MRI scan is the best imaging test for visualizing a suspected brain tumor. By injecting a contrast dye, doctors can look for specific patterns, such as a bright ring surrounding a darker center, which helps them assess the tumor and plan for surgery.
Can an MRI definitively diagnose glioblastoma?
No, an MRI alone cannot provide a definitive diagnosis. Other conditions, such as brain infections or different types of cancers, can look nearly identical to a glioblastoma on a scan. A physical sample of the tissue must be examined by a pathologist to confirm the disease.
Why do doctors need to do genetic or molecular testing on the tumor?
Molecular testing looks at the specific genetic markers inside the tumor cells, such as IDH mutation status. This analysis is required under modern guidelines to confirm exactly what type of tumor you have and to ensure you receive the most appropriate and effective treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the MRI, does the tumor show 'ring enhancement' or 'necrosis,' and what does that suggest?
  2. 2.If we only do a needle biopsy instead of a resection, will we have enough tissue for full molecular testing?
  3. 3.How are we ruling out mimics like a brain abscess or primary central nervous system lymphoma (PCNSL)?
  4. 4.Will you be using advanced imaging like Perfusion-Weighted Imaging (PWI) or MR Spectroscopy (MRS) to help plan the surgery?
  5. 5.What specific focal neurological deficits are you seeing based on the tumor's location on my scans?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Pre-Surgery Cognitive Performance and Voxel-Based Lesion-Symptom Mapping in Patients with Left High-Grade Glioma.

    Guarracino I, Ius T, Baiano C, et al.

    Cancers 2021; (13(6)) doi:10.3390/cancers13061467.

    PMID: 33806837
  2. 2

    Palliative Care in High-Grade Glioma: A Review.

    Crooms RC, Goldstein NE, Diamond EL, Vickrey BG

    Brain sciences 2020; (10(10)) doi:10.3390/brainsci10100723.

    PMID: 33066030
  3. 3

    Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.

    Sekely A, Bernstein LJ, Campbell KL, et al.

    Neuro-oncology practice 2023; (10(1)):89-96 doi:10.1093/nop/npac068.

    PMID: 36659968
  4. 4

    The many faces of glioblastoma: Pictorial review of atypical imaging features.

    Khandwala K, Mubarak F, Minhas K

    The neuroradiology journal 2021; (34(1)):33-41 doi:10.1177/1971400920965970.

    PMID: 33081585
  5. 5

    Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI.

    Cai X, Chen Z, Chang B, et al.

    Frontiers in oncology 2022; (12()):937345 doi:10.3389/fonc.2022.937345.

    PMID: 36003762
  6. 6

    Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging.

    Prada F, Vitale V, Del Bene M, et al.

    Radiology 2017; (285(1)):242-249 doi:10.1148/radiol.2017161206.

    PMID: 28562204
  7. 7

    Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.

    Wu H, Tong H, Du X, et al.

    European radiology 2020; (30(6)):3254-3265 doi:10.1007/s00330-020-06702-2.

    PMID: 32078014
  8. 8

    Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients.

    Yoo RE, Choi SH

    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 2016; (15(2)):165-77 doi:10.2463/mrms.rev.2015-0053.

    PMID: 26726012
  9. 9

    Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

    Gonçalves FG, Chawla S, Mohan S

    Journal of magnetic resonance imaging : JMRI 2020; (52(4)):978-997 doi:10.1002/jmri.27105.

    PMID: 32190946
  10. 10

    Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.

    Stoyanov GS, Lyutfi E, Georgieva R, et al.

    Cureus 2022; (14(2)):e21822 doi:10.7759/cureus.21822.

    PMID: 35291535
  11. 11

    Pyogenic brain abscess with atypical features resembling glioblastoma in advanced MRI imaging.

    Hakim A, Oertel M, Wiest R

    Radiology case reports 2017; (12(2)):365-370 doi:10.1016/j.radcr.2016.12.007.

    PMID: 28491190
  12. 12

    Differentiation of high-grade glioma and primary central nervous system lymphoma based on imaging heterogeneity scoring system.

    Liu M, Li J, Xue C, et al.

    Neurosurgical review 2026; (49(1)):145 doi:10.1007/s10143-025-03937-9.

    PMID: 41575657
  13. 13

    Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis.

    Liu Z, Jiang Z, Meng L, et al.

    Journal of oncology 2021; (2021()):5518717 doi:10.1155/2021/5518717.

    PMID: 34188680
  14. 14

    Molecular GBM versus Histopathological GBM: Radiology-Pathology-Genetic Correlation and the New WHO 2021 Definition of Glioblastoma.

    Agarwal A, Edgar MA, Desai A, et al.

    AJNR. American journal of neuroradiology 2024; (45(8)):1006-1012 doi:10.3174/ajnr.A8225.

    PMID: 38438167
  15. 15

    MALDI Imaging Mass Spectrometry of High-Grade Gliomas: A Review of Recent Progress and Future Perspective.

    Rončević A, Koruga N, Soldo Koruga A, et al.

    Current issues in molecular biology 2023; (45(2)):838-851 doi:10.3390/cimb45020055.

    PMID: 36826000

This page explains glioblastoma symptoms and diagnostic procedures for educational purposes only. Always consult a neurologist or oncologist for proper evaluation and diagnosis of neurological symptoms.

Get notified when new evidence is published on Glioblastoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.